Standout Papers

Bimekizumab versus Secukinumab in Plaque Psoriasis 2021 2026 2022 2024214
  1. Bimekizumab versus Secukinumab in Plaque Psoriasis (2021)
    Kristian Reich, Richard B. Warren et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 57 standout
Sub-graph 1 of 22

Citing Papers

Dynamic GelMA/DNA Dual‐Network Hydrogels Promote Woven Bone Organoid Formation and Enhance Bone Regeneration
2025 Standout
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
1 intermediate paper

Works of Dirk De Cuyper being referenced

Bimekizumab versus Secukinumab in Plaque Psoriasis
2021 Standout
Bimekizumab versus Adalimumab in Plaque Psoriasis
2021

Author Peers

Author Last Decade Papers Cites
Dirk De Cuyper 389 74 62 175 122 17 494
A. Maza 283 157 50 206 125 23 573
Mahir Patel 215 90 33 198 78 17 459
Hongqing Tian 324 47 12 218 147 25 572
Géraldine Bart 241 34 25 133 107 25 472
Georgia Avgerinou 189 135 37 225 107 33 554
TH. JOOST 155 144 40 278 96 15 528
Angelique N. Collamer 309 123 18 108 221 10 564
S.P. Menting 497 49 12 191 97 13 573
Jinhua Xu 359 42 18 135 97 22 525
Beatriz Pérez-Zafrilla 225 82 30 54 239 17 515

All Works

Loading papers...

Rankless by CCL
2026